Fonte: Current Medicinal Chemistry. Unidade: FCFRP
Assuntos: ANTICORPOS MONOCLONAIS, ANTINEOPLÁSICOS, NANOPARTÍCULAS, NEOPLASIAS, FARMACOTERAPIA
ABNT
PETRILLI, Raquel et al. Immunoconjugates for cancer targeting: a review of antibody-drug conjugates and antibody-functionalized nanoparticles. Current Medicinal Chemistry, v. 28, n. 13, p. 2485-2520, 2021Tradução . . Disponível em: https://doi.org/10.2174/0929867327666200525161359. Acesso em: 23 out. 2025.APA
Petrilli, R., Pinheiro, D. P., Oliveira, F. de C. E. de, Galvão, G. F., Marques, L. G. A., Lopez, R. F. V., et al. (2021). Immunoconjugates for cancer targeting: a review of antibody-drug conjugates and antibody-functionalized nanoparticles. Current Medicinal Chemistry, 28( 13), 2485-2520. doi:10.2174/0929867327666200525161359NLM
Petrilli R, Pinheiro DP, Oliveira F de CE de, Galvão GF, Marques LGA, Lopez RFV, Pessoa C, Eloy JO. Immunoconjugates for cancer targeting: a review of antibody-drug conjugates and antibody-functionalized nanoparticles [Internet]. Current Medicinal Chemistry. 2021 ; 28( 13): 2485-2520.[citado 2025 out. 23 ] Available from: https://doi.org/10.2174/0929867327666200525161359Vancouver
Petrilli R, Pinheiro DP, Oliveira F de CE de, Galvão GF, Marques LGA, Lopez RFV, Pessoa C, Eloy JO. Immunoconjugates for cancer targeting: a review of antibody-drug conjugates and antibody-functionalized nanoparticles [Internet]. Current Medicinal Chemistry. 2021 ; 28( 13): 2485-2520.[citado 2025 out. 23 ] Available from: https://doi.org/10.2174/0929867327666200525161359